share_log

ノイルイミューン・バイオテック:(訂正)「自社創薬パイプラインの優先度再設定及びそれに伴う上場時調達資金使途変更に関するお知らせ」の一部訂正について

Noile-Immune Biotech: (Correction) Partial Corrections to the “Notice Concerning Prioritization of Our Drug Discovery Pipeline and Associated Changes in the Use of Funds Raised at the Time of Listing”

JPX ·  Oct 11 03:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more